Browse > Article
http://dx.doi.org/10.3904/kjim.2013.28.4.413

Recent trends in hepatitis B virus infection in the general Korean population  

Kim, Hyuck (Department of Internal Medicine, Kyung Hee University Medical Center)
Shin, A Ri (Department of Internal Medicine, Kyung Hee University Medical Center)
Chung, Hoe Hoon (Department of Internal Medicine, Kyung Hee University Medical Center)
Kim, Min Kyoung (Department of Internal Medicine, Kyung Hee University Medical Center)
Lee, Ji Sung (Department of Biostatistics, Korea University College of Medicine)
Shim, Jae-Jun (Department of Internal Medicine, Kyung Hee University Medical Center)
Kim, Byung-Ho (Department of Internal Medicine, Kyung Hee University Medical Center)
Publication Information
The Korean journal of internal medicine / v.28, no.4, 2013 , pp. 413-419 More about this Journal
Abstract
Background/Aims: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population. Methods: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010). Results: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged 10 to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers. Conclusions: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.
Keywords
Age groups; Hepatitis B surface antigens; Hepatitis B virus; Prevalence; Korea;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84:405-419.
2 Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990;8 Suppl:S18-S20.   DOI   ScienceOn
3 Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-1539.
4 Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000;19:1026-1037.   DOI   ScienceOn
5 Jang KM, Woo SH, Yun DH, et al. Seroepidemiologic survey on type B viral hepatitis in inchon area, Department of Internal Medicine, Inchon Christian Hospital. Korean J Med 1983;26:1331-1336.
6 Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci (Boston) 2011;4:7-13.
7 Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010;53:20-28.   DOI   ScienceOn
8 Korea Centers for Disease Control and Prevention. The fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1) [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention, 2010 [cited 2012 May 10]. Available from: http://knhanes.cdc.go.kr.
9 Lin HH, Wang LY, Hu CT, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003;69:471-474.   DOI   ScienceOn
10 Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102.
11 Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54(RR-16):1-31.
12 Ahn YO, Kim CY, Bae SH, Chang HG. Changing pattern of HBV-related diseases in Korea since after HBV vaccination. Korean J Hepatol 2010;16(4 Suppl):S23-S37.
13 Han BS, Kim IS, Suh I. A study of the seroconversion rates of anti HBs and the duration of anti HBS persistence after hepatitis B vaccination. Korean J Epidemiol 1989;11:215-231.
14 Hwang SH, Oh HB, Kim HS, Lee EY. Evaluation of HBs Ag, HCV and HIV Ag-Ab assays using Bio-Rad elite microplate analyzer. Korean J Lab Med 2006;26:436-441.   DOI   ScienceOn
15 Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009;15 Suppl 6:S13-S24.   DOI   ScienceOn
16 Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24.   DOI   ScienceOn
17 Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000;284:3040-3042.   DOI   ScienceOn
18 Manetta T, Gay V, Spreafico G, Massaro A, Piantino P. Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300. Minerva Med 2001;92:393-400.
19 Louisirirotchanakul S, Khupulsup K, Akraekthalin S, et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol 2010;82:755-762.   DOI   ScienceOn
20 Louisirirotchanakul S, Kanoksinsombat C, O'Charoen R, et al. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant. Viral Immunol 2006;19:108-114.   DOI   ScienceOn
21 Xu W, Li Y, Wang M, Gu J. Comparison of two immunoassays for determining hepatitis B virus serum markers. Clin Chem Lab Med 2011;50:153-157.